Stocklytics Platform
Asset logo for symbol GLYC
GlycoMimetics
GLYC58
$0.31arrow_drop_down0.93%-$0.00
Penny Stock
Asset logo for symbol GLYC
GLYC58

$0.31

arrow_drop_down0.93%

Performance History

Chart placeholder
Key Stats
Open$0.31
Prev. Close$0.33
EPS-0.62
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$20.63M
PE Ratio-
LOWHIGH
Day Range0.30
0.33
52 Week Range0.15
3.53
Ratios
Revenue-
EBITDA Margin %-
EPS-0.62

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About GlycoMimetics (GLYC)

GlycoMimetics Inc (GLYC) is a biotechnology company focused on the development of novel therapies for various diseases, particularly those in the areas of oncology and hematology. With a strong pipeline and a commitment to groundbreaking research, GLYC is positioned to make a significant impact in the healthcare industry. The company's stock price history reflects the market's recognition of its potential, with consistent growth over the years.
As of the latest quote, GLYC is trading at $18.45 per share. This represents a significant increase from its initial public offering (IPO) price and demonstrates investor confidence in the company's prospects. GLYC's market capitalization is currently around $1.3 billion, reflecting the company's growing prominence in the biotech sector.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Harout Semerjian
Headquarters
Rockville
Employees
38
Exchange
NASDAQ
add GlycoMimetics  to watchlist

Keep an eye on GlycoMimetics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the 52-week high and low for GlycoMimetics (GLYC)?

For GlycoMimetics (GLYC), the 52-week high is $3.53, which is 1.01K% from the current price. The 52-week low is $0.15, the current price is 111.2% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

What is GlycoMimetics 's (GLYC) price per share?

The current price per share for GlycoMimetics (GLYC) is $0.32. The stock has seen a price change of -$0 recently, indicating a -0.94% change. This reflects the stock's recent market performance and investor sentiment.
help

Is GlycoMimetics (GLYC) a growth stock?

GlycoMimetics (GLYC) has shown an average price growth of -6.03% over the past three years. It has received a score of 14 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying GlycoMimetics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is GlycoMimetics (GLYC) stock price performance year to date (YTD)?

As of the latest data, GlycoMimetics (GLYC) has a year-to-date price change of -88.35%. Over the past month, the stock has experienced a price change of 98%. Over the last three months, the change has been 71.24%. Over the past six months, the figure is 15.03%. Looking at a longer horizon, the five-year price change stands at -94.05%.
help

Is GlycoMimetics (GLYC) a profitable company?

GlycoMimetics (GLYC) has a net income of -$36.9M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -408.77K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$39.28M. Furthermore, the EBITDA is -$40.78M.
help

What is the market capitalization of GlycoMimetics (GLYC)?

GlycoMimetics (GLYC) has a market capitalization of $20.43M. The average daily trading volume is 0.32, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level